We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of VIVO yet.

VIVO Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2026, worth a combined $34 — unchanged from a quarter earlier.

Fund positioning in VIVO was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Meridian Bioscience Inc (VIVO) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $34 of Meridian Bioscience Inc stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Meridian Bioscience Inc positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.